Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
22
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Posco Future M
•
22 May 2023 07:03
Korea: What Are Foreign Investors Buying & Selling?
Foreign investors have been buying stock in Korea and hold 32% of the KOSPI market cap and 8.5% of the KOSDAQ market cap. There is a big dispersion...
Brian Freitas
Follow
462 Views
Share
bullish
•
SK Pharmteco
•
17 May 2023 17:11
SK Pharmteco Pre-IPO Funding & Impact on SK Inc
SK Pharmteco is seeking valuation of about 5 trillion won which is much higher than its book value of 1.65 trillion won. SK Pharmteco (100% owned...
Douglas Kim
Follow
348 Views
Share
bullish
•
Celltrion Inc
•
15 May 2023 17:37
Celltrion Inc (068270 KS): Turning Bullish As Biosimilar Revenue Rebounds & US Launches Imminent
Celltrion reported record-high biosimilar quarterly revenue of KRW400B+ in Q1, leading to double-digit revenue and operating profit growth. The...
Tina Banerjee
Follow
263 Views
Share
bullish
•
Quantitative Analysis
•
03 Apr 2023 05:47
Short Interest Movements (Q1 2023): HK, Korea, Taiwan, Australia
The Insight looks at movements in short interest across HK, Korea, Taiwan and Australia stocks over Q1 and highlights large increases/decreases in...
Brian Freitas
Follow
444 Views
Share
bullish
•
Mirae Asset Tiger Top 10 ETF
•
06 Mar 2023 14:53
Long Short Setup Candidate: Posco Holdings & Celltrion with TIGER Top 10 Rebalancing
TIGER Top 10 ETF's upcoming rebalancing, scheduled for June 9, presents a feasible long short trade setup on Posco Holdings and Celltrion.
Sanghyun Park
Follow
415 Views
Share
First
Previous
33
34
35
36
37
38
39
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x